Latest News from: Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Filters close
Released: 22-Sep-2020 8:00 AM EDT
MEDIA ALERT: MSVirtual2020
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The MSVirtual2020 program will continue in an Encore Program that will be held on Saturday, September 26th from 9:00 a.m. – 12:15 p.m. ET. This Encore Program will feature the Late Breaker (9-10:30 a.m. ET) and COVID-19th (10:45 a.m. – 12:15 p.m. ET) sessions.

Released: 11-Sep-2020 6:15 PM EDT
Welcome Letter from ACTRIMS President on MSVirtual2020
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

It is with great pleasure that I welcome you to the 8th joint ACTRIMS-ECTRIMS conference. This conference, MSVirtual2020, is the largest conference dedicated to multiple sclerosis (MS) research and our first virtual conference.

Released: 9-Sep-2020 8:00 AM EDT
Registered Reporters Are Invited to Three Virtual MSVirtual2020 Press Conferences Featuring: The Latest Clinical Study Outcomes, Advances in Therapeutics, Diagnostics and Technologies, and Late Breakers and COVID-19 Impact on MS Research & Patient Care
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The 8th Joint ACTRIMS-ECTRIMS meeting – the largest international conference focused on research in multiple sclerosis (MS), will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News and a COVID-19 Session on September 26.

Newswise: The Facts About Multiple Sclerosis
Released: 2-Sep-2020 9:00 AM EDT
The Facts About Multiple Sclerosis
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

In just the U.S. alone, more than 200 individuals are diagnosed with Multiple Sclerosis (MS) each week. However, when properly managed and controlled with medications and lifestyle adjustments, many of the common MS symptoms like visual and sensory loss, weakness and impared cognition can be mitigated.

Released: 2-Sep-2020 7:00 AM EDT
The 8th Joint ACTRIMS-ECTRIMS Meeting - MSVirtual2020 - To be Held September 11-13 With A Special Encore Session Featuring COVID-19 & MS and Late Breakers on September 26th
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest international conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News and a COVID-19 Session on September 26.

Released: 13-Aug-2020 9:00 AM EDT
Largest International Multiple Sclerosis Research Conference in September 2020
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore featuring Late-Breaking News and a COVID-19 Session on September 26.

Released: 30-Jun-2020 8:00 AM EDT
8th Joint ACTRIMS-ECTRIMS (MSVirtual2020) Meeting to Be Held Virtually September 11-13, 2020 with an Encore Event on September 26th with Late Breakers and Special Session on COVID-19
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Registered media to MSVirtual2020 will have access to the full program including plenary sessions, invited speakers and platform presentations of abstracts, poster presentations, teaching courses, and industry supported satellite symposia, both scheduled and on-demand

Released: 29-Jun-2020 11:30 AM EDT
Letter from ACTRIMS President on MSVirtual2020
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

I am pleased to announce that the 8th Joint ACTRIMS-ECTRIMS Meeting will be held from September 11-13, 2020, with a special encore featuring Late-Breaking News and a COVID-19 Session on September 26.

Newswise: Neurology Professor from Harvard Medical School Wins Barancik Prize for Innovation in MS Research for Work Resulting in New Tools and Treatments to Combat MS
Released: 20-Feb-2020 4:30 PM EST
Neurology Professor from Harvard Medical School Wins Barancik Prize for Innovation in MS Research for Work Resulting in New Tools and Treatments to Combat MS
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Dr. Francisco J. Quintana to receive the award and deliver the Barancik Prize lecture at the ACTRIMS Forum 2020 for work resulting in new tools and treatments to combat MS

Newswise: New Research Links Genetics and MS Severity, Offers Innovative Treatment Ideas to Combat MS and Other Neurodegenerative Diseases
Released: 18-Feb-2020 3:25 PM EST
New Research Links Genetics and MS Severity, Offers Innovative Treatment Ideas to Combat MS and Other Neurodegenerative Diseases
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Dr. Peter Calabresi, professor of Neurology and Neuroscience at the Johns Hopkins School of Medicine and Director of the Johns Hopkins Multiple Sclerosis (MS) Center, will present his team’s discovery of a possible link between severe damage and C3 and C1q gene variants, and how this information could lead to improvements in the ways MS and other neurodegenerative diseases are treated, during his keynote Kenneth P. Johnson Memorial Lecture on the opening day of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2020.

Newswise: Networks in multiple sclerosis will be the focus at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2020 Forum
Released: 6-Dec-2019 4:50 PM EST
Networks in multiple sclerosis will be the focus at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2020 Forum
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Approximately 1,200 researchers and clinicians are expected to attend the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual Forum Feb. 27-29, 2020, in West Palm Beach, Florida.

Newswise: University of California Scientist Wins Barancik Prize for Innovation in MS Research
Released: 21-Jan-2019 3:05 PM EST
University of California Scientist Wins Barancik Prize for Innovation in MS Research
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Professor Katerina Akassoglou to receive 2018 Prize for work understanding the origins of nerve damage in MS and identifying potential therapies to stop it.

Newswise: Tailored Disability-Specific Neuroprotective Treatment Development in MS Offers a Potential New Approach
Released: 27-Nov-2018 4:55 PM EST
Tailored Disability-Specific Neuroprotective Treatment Development in MS Offers a Potential New Approach
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Dr. Rhonda Voskuhl professor at the University of California, Los Angeles, will present her hypothesis that molecular mechanisms underlying each disability may differ from each other based on regional differences in neurons, astrocytes and oligodendrocytes as the subject of the keynote Kenneth P. Johnson Memorial Lecture on the opening day of the ACTRIMS Forum 2019.

Newswise: ACTRIMS Recognizes Young Investigators at Forum 2018
Released: 26-Feb-2018 12:05 PM EST
ACTRIMS Recognizes Young Investigators at Forum 2018
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) recognized the research contributions of five young investigators during the recent ACTRIMS Forum 2018. Abstracts and posters can be found in the ACTRIMS Forum online program, and will be published in the MS Journal.

Newswise: Barancik Prize To Be Presented at ACTRIMS Forum 2018
Released: 14-Dec-2017 12:05 PM EST
Barancik Prize To Be Presented at ACTRIMS Forum 2018
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Professor Robin Franklin to receive the 2017 Barancik Prize for pioneering work to restore function for people with progressive MS. He will receive the award at ACTRIMS Forum 2018 on February 1 in San Diego, California.

Newswise: Suhayl Dhib-Jalbut, M.D., to Present Findings in Keynote Address at ACTRIMS Forum 2018
Released: 30-Nov-2017 2:05 PM EST
Suhayl Dhib-Jalbut, M.D., to Present Findings in Keynote Address at ACTRIMS Forum 2018
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

New findings uncover the mechanisms by which gut bacteria can trigger inflammation in the brain and contribute to multiple sclerosis

Newswise: Therapeutic Targets in Multiple Sclerosis Will Be Featured at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2018 Forum
Released: 11-Aug-2017 10:05 AM EDT
Therapeutic Targets in Multiple Sclerosis Will Be Featured at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2018 Forum
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

ACTRIMS' third annual forum will be Feb. 1-3 in San Diego, California and will focus on therapeutic targets in multiple sclerosis with emphasis on disease-modifying therapies. New at the 2018 forum is the presentation by the National Multiple Sclerosis Society of the Barancik Prize for Innovation in Multiple Sclerosis Research, recognizing work in MS research that demonstrates outstanding innovation and originality.

Released: 9-Mar-2017 10:05 AM EST
ACTRIMS Recognizes Young Investigators at Forum 2017
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Abstracts from Environmental Factors, Genetics and Epigenetics in MS Susceptibility and Clinical Course are now available at Multiple Sclerosis Journal.

Released: 23-Feb-2017 3:05 PM EST
Environmental Factors, Genetics and Epigenetics Is Focus of Multiple Sclerosis Forum
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The second annual ACTRIMS Forum gets underway today. This year, the forum was preceded by the Neurology Resident Summit in Neuroimmunology, which drew 47 residents from the United States and Canada.

Released: 20-Dec-2016 4:05 PM EST
New Understanding of Autoimmune Function in MS Is Described as a Breakthrough
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

A new, highly effective multiple sclerosis therapy will be presented at the America’s Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2017, Thursday, Feb. 23, in Orlando.

Newswise: Americas Committee for Treatment and Research in Multiple Sclerosis Announces 2017 Forum
Released: 1-Aug-2016 11:05 AM EDT
Americas Committee for Treatment and Research in Multiple Sclerosis Announces 2017 Forum
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Environmental factors, genetics and epigenetics in multiple sclerosis susceptibility and clinical course is focus of ACTRIMS Forum 2017.

Released: 26-Feb-2016 11:05 AM EST
Late-Breaking Research Shows Promise for Patients with Primary Progressive Multiple Sclerosis
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Abstract describes efficacy of ocrelizumab in patients with PPMS with and without T1 gadolinium-enhancing lesions at baseline in a Phase III, placebo-controlled trial.

Released: 23-Feb-2016 5:05 PM EST
ACTRIMS 2016 Concludes With Young Investigator Awards
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Opportunities for young investigators to present their findings and consult with established researchers and clinicians were among the primary goals of ACTRIMS Forum 2016. The event drew more than 600 participants to New Orleans.

Released: 18-Feb-2016 7:05 PM EST
North America’s Leading MS Experts Meet in New Orleans
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

More than 500 clinicians and researchers are meeting in New Orleans to share the latest information about progressive multiple sclerosis.

Released: 18-Feb-2016 10:05 AM EST
Late-Breaking Abstracts From ACTRIMS 2016 Now Available
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? Roberta Magliozzi, Ph.D., Imperial College, London, UK

Released: 18-Feb-2016 10:05 AM EST
Late-Breaking Abstracts Now Available From ACTRIMS 2016
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Jennifer S. Graves M.D., Ph.D., University of California at San Francisco will present one of three late-breaking abstracts at ACTRIMS 2016

Released: 9-Dec-2015 2:05 PM EST
Distinguishing Among Forms of MS Will Lead to Better Treatments
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Jerry S. Wolinsky, M.D., will deliver the first annual Kenneth P. Johnson Memorial Lecture at ACTRIMS Forum 2016, Feb. 18 - 20, 2016, in New Orleans. Americas Committee for Treatment and Research in Multiple Sclerosis is hosting its first-ever standalone forum for researchers and clinicians to share the latest developments.

Released: 25-Sep-2015 3:05 PM EDT
ACTRIMS Announces First Independent Forum
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

ACTRIMS Forum 2016, the first standalone event for the Americas Committee for Treatment and Research in Multiple Sclerosis, will feature the latest research results and bring together researchers and clinicians from the United States and Canada.

Newswise: First Research Studies Launched in 9 Countries as Part of €22 Million Global Effort to End Progressive Multiple Sclerosis
8-Sep-2014 8:00 AM EDT
First Research Studies Launched in 9 Countries as Part of €22 Million Global Effort to End Progressive Multiple Sclerosis
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The International Progressive MS Alliance has awarded its first round of 22 research grants to investigators in 9 countries, with the goal of removing barriers to developing treatments for progressive MS. The Alliance is a worldwide collaborative focused on finding solutions to progressive forms of multiple sclerosis that have so far eluded the scientific community.

8-Sep-2014 4:05 PM EDT
Progressive MS Alliance Grant Funding
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The International Progressive MS Alliance has awarded its first round of 22 research grants to investigators in 9 countries, with the goal of removing barriers to developing treatments for progressive MS. The Alliance is a worldwide collaborative focused on finding solutions to progressive forms of multiple sclerosis that have so far eluded the scientific community.

Newswise:Video Embedded oceans-of-hope-video
VIDEO
Released: 11-Sep-2014 4:00 PM EDT
Oceans of Hope Video
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Oceans of Hope was created by the Sailing Sclerosis Foundation to change perceptions of multiple sclerosis by showing what is possible when people with a chronic disease are empowered to conquer their individual challenges. The 20-meter yacht, Oceans of Hope< is undertaking the first global circumnavigation by a crew of people with MS.


Showing results

150 of 63

close
2.2792